Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
1.080
-0.010 (-0.92%)
At close: Jun 16, 2026, 4:00 PM EDT
1.260
+0.180 (16.67%)
After-hours: Jun 16, 2026, 7:59 PM EDT
Onconetix Revenue
Onconetix had revenue of $21.46K in the quarter ending March 31, 2026, a decrease of -78.89%. This brings the company's revenue in the last twelve months to $735.20K, down -61.81% year-over-year. In the year 2025, Onconetix had annual revenue of $815.37K, down -67.70%.
Revenue (ttm)
$735.20K
Revenue Growth
-61.81%
P/S Ratio
1.68
Revenue / Employee
$367,599
Employees
2
Market Cap
1.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 815.37K | -1.71M | -67.70% |
| Dec 31, 2024 | 2.52M | 2.47M | 4,217.31% |
| Dec 31, 2023 | 58.47K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jaguar Health | 29.57M |
| Ensysce Biosciences | 4.71M |
| Scinai Immunotherapeutics | 1.21M |
| Biodexa Pharmaceuticals | 104.90K |
| Aspire Biopharma Holdings | 34.56K |
ONCO News
- 7 hours ago - Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization - Accesswire
- 7 days ago - Onconetix Registration statement: Registration filing - Filings
- 7 days ago - Onconetix files to sell 100M shares of common stock for holders - TheFly
- 27 days ago - Onconetix Inc trading halted, news pending - TheFly
- 4 weeks ago - Onconetix announces 1-for-10 reverse stock split - TheFly
- 4 weeks ago - Onconetix, Inc. Announces 1-for-10 Reverse Stock Split - GlobeNewsWire
- 4 weeks ago - Realbotix expects transaction with Onconetix to close by October - TheFly
- 4 weeks ago - Realbotix Provides Update on Nasdaq Listing - Business Wire